Activated Prothrombin Concentrate for Patients with Factor VIII Inhibitors

New England Journal of Medicine

Volumn 291, Issue 4, 1974, Pages 164-167

  Kurczynski, Elizabeth M ^a   Penner, John A ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8 ANTIBODY; BLOOD CLOTTING FACTOR 9; FIBRIN DEGRADATION PRODUCT; PROTHROMBIN;

HEMOPHILIA A; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; THERAPY;

EID: 0016213054     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197407252910402     Document Type: Article

References (14)

1. Roberts HR, Knowles MR, Jones TL, et al: Use of factor VIII concentrates in the management of patients with factor VIII inhibitors, Hemophilia and New Hemorrhagic States. Edited by KM Brinkhous. Chapel Hill, University of North Carolina Press, 1970, pp 152–163
2. Green D: Suppression of an antibody to factor VIII by a combination of factor VIII and cyclophosphamide. Blood 37: 381–387, 1971
3. Lusher JM, Iyer R: Effective suppression of factor VIII antibody in patients with hemophilia A with cyclophosphamide, Proceedings of the VII Congress of the World Federation of Haemophilia (International Congress Series No 252). Amsterdam, Excerpta Medica, 1971, pp 272–274
4. Roberts HR, Scales MB, Madison JT, et al: A clinical and experimental study of acquired inhibitors to factor VIII. Blood 26: 805–818, 1965
5. Strauss HS: Acquired circulating anticoagulants in hemophilia A. N Engl J Med 281: 866–873, 1969
6. Fekete LF, Holst SL, Peetoom F, et al: “Auto”-Factor IX concentrate: a new therapeutic approach to treatment of hemophilia A patients with inhibitors. Presented at the fourteenth International Congress of Hematology, São Paulo, Brazil, July, 1972, abstr 295
7. Langdell RD, Wagner RH, Brinkhous KM: Estimation of antihemophilic activity by partial thromboplastin time technic, Blood Coagulation, Hemorrhage, and Thrombosis. Edited by LM Tocantins, LA Kazal. New York, Grune and Stratton, 1964, p 107
8. Barrow EM, Graham JB: Estimation of factor X (Stuart-Prower factor) activity utilizing the prothrombin time technic, Blood Coagulation, Hemorrhage and Thrombosis. Edited by LM Tocantins, LA Kazal. New York, Grune and Stratton, 1964, p 127
9. Niewiarowski S, Gurewich V: Laboratory identification of intravascular coagulation: serial dilution protamine sulfate test for the detection of fibrin monomer and fibrin degradation products. J Lab Clin Med 77: 665–676, 1971
10. Cohen LE, McNeill CJ, Wells RF: Clindamycin-associated colitis. JAMA 223: 1379–1380, 1973
11. Penner JA, Seegers WH: Activation of prothrombin. Am J Physiol 186: 343–349, 1956
12. Seegers WH, Marciniak E: Normal blood-clotting compared with hemophilia B, Hemophilia and the New Hemorrhagic States. Edited by KM Brinkhous. Chapel Hill, University of North Carolina Press, 1970, pp 43–52
13. Kasper CK: Postoperative thromboses in hemophilia B. N Engl J Med 289: 160, 1973
14. Gehrke CF, Penner JA: Antihemophilic factor inhibitors: response to therapy. Clin Res 20: 740, 1972